150 Followers on Owler

NeRRe

Read more
Mary Kerr's photo - CEO of NeRRe

CEO

Mary Kerr

CEO Approval Rating

73/100

Founded:

2012

Status:

PrivateIndependent Company

Est. Annual Revenue
$2.4M
Agree?
Est. Employees
13
Agree?

NeRRe News

Social Media

NeRRe Headquarters

Gunnels Wood Road Stevenage Bioscience Catalyst, Incubator Building

Stevenage, EnglandSG1 2FX

44-1438-906-960

Driving Directions »

NeRRe Summary

ABOUT

Overview

Nerre is an England-based clinical-stage pharmaceutical company that researches and develops neurokinin receptor antagonist drugs to treat cough hypersensitivity disorders. NeRRe was founded in 2012. NeRRe's headquarters is located in Stevenage, Engla...

CEO

NeRRe's CEO, Mary Kerr, currently has an approval rating of 73%. NeRRe's primary competitors are Alitair, BELLUS Health & Roivant.

Acquisitions

There have been no acquisitions found related to NeRRe

Investments

Recent investment data cannot be found related to NeRRe

Frequently Asked Questions about NeRRe

  1. When was NeRRe founded?

    NeRRe was founded in 2012
  2. Who is NeRRe's CEO?

    NeRRe's CEO is Mary Kerr
  3. How much revenue does NeRRe generate?

    NeRRe generates $2.4M in revenue
  4. How much funding does NeRRe have?

    NeRRe has historically raised $74.3M in funding
  1. Where is NeRRe's headquarters?

    NeRRe's headquarters is in Stevenage England, GB
  2. How many employees does NeRRe have?

    NeRRe has 13 employees
  3. What sector does NeRRe operate in?

    NeRRe is in Pharmaceuticals
  4. Who are NeRRe's competitors?

    NeRRe's top competitors are Alitair, BELLUS Health, Roivant

Trending Companies